# IndieBio

IndieBio is a Venture Capital based in San Francisco, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** indiebio.co
- **LinkedIn:** https://www.linkedin.com/company/indiebio

## Regulatory record

- **Reports private funds:** No

## About

IndieBio is a startup development program focused on bioscience, founded in 2015 in San Francisco, California. The company works with scientists to develop business skills. IndieBio has made 747 investments, including a Seed VC investment in FluoSphera on January 12, 2026.

## Sectors

- Biotechnology
- AI/ML
- ClimateTech
- AgriTech & FoodTech
- Digital Health

## Offices

- New York, NY, United States

## People

- Aron Jazayeri — General Partner
- Po Bronson — Managing Director

## Questions

### How does IndieBio's program actually work for a founding scientist?

IndieBio accepts pre-seed companies into a four-month accelerator that provides $250,000 in initial funding alongside access to fully equipped wet-lab space in San Francisco or New York. Founders relocate to the lab and receive hands-on mentorship in company building, scientific de-risking, and fundraising. The program concludes with a Demo Day where companies present to later-stage life-science investors.

### Who runs investment decisions at IndieBio?

Po Bronson serves as Managing Director and leads the broader investment thesis and mentor network. Aron Jazayeri is a General Partner focused on deal selection and portfolio support. Investment decisions are collegial but ultimately sit with the IndieBio leadership team within the larger SOSV partnership structure.

### How is IndieBio related to SOSV?

IndieBio is a wholly owned accelerator program of SOSV, the multi-stage venture capital firm. SOSV provides the fund capital, back-office infrastructure, and follow-on investment capacity. IndieBio operates with its own brand, scientific advisory network, and lab facilities, but its portfolio companies go through the SOSV investment committee for any subsequent funding rounds.

### Which sectors does IndieBio explicitly avoid?

IndieBio does not invest in traditional small-molecule drug development aimed at large chronic-disease markets, nor does it back therapeutic approaches intended to run through multi-year FDA approval processes within the fund's life. The program also avoids software-only companies; there must be a physical biology or deep-tech hardware component to the startup's approach.

### Does IndieBio participate in fund commitments or only direct deals?

IndieBio only makes direct investments into individual startups. It does not invest as a limited partner in other venture funds. The firm's capital comes from SOSV's core funds, and those SOSV vehicles are the sole investment vehicles used for IndieBio portfolio companies.

## Related profiles

- [Indico Capital](https://altss.com/profile/indico-capital)
- [Indie.vc](https://altss.com/profile/indie-enterprises)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/indiebio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology